CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended
	Feb. 28, 2013	Feb. 29, 2012
Revenue	$ 12,329	$ 12,329
Operating expenses
Selling, general and administrative	210,185	232,554
Research and development	39,625	52,144
Stock-based compensation	99,868	13,172
Total operating expenses	349,678	297,870
Loss from operations	(337,349)	(285,541)
Other income (expense)
Interest expense	(671)	(5,850)
Change in fair value of derivative liability	(47,900)	1,227
Interest income	75	274
Total other income (expense)	(48,496)	(4,349)
Net loss	(385,845)	(289,890)
Less net loss attributable to the noncontrolling interests	(26,880)	(19,320)
Net loss attributable to MultiCell Technologies, Inc.	$ (358,965)	$ (270,570)
Basic and Diluted Loss Per Common Share (in dollars per share)	$ (0.00026)	$ (0.00031)
Basic and Diluted Weighted-Average Common Shares Outstanding (in shares)	1,400,538,832	863,541,087